Literature DB >> 11156338

Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum.

F Pagani1, G Bonetti, F Stefini, M Panteghini.   

Abstract

The measurement of the degradation product of the C-telopeptide of type I collagen in serum (s-betaCTX) has been evaluated in the form of an automated chemiluminometric assay. The between-day coefficients of variation ranged between 2.6 and 6.0% over the concentration range 0.12 to 3.25 microg/l. The s-betaCTX value correlated well with alternative serum C-telopeptide (r = 0.983) and urine deoxypyridinoline (r = 0.729) measurements. A significant inverse correlation was found between the s-betaCTX measurement and creatinine clearance in patients with renal disease.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11156338     DOI： 10.1515/CCLM.2000.166

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


  6 in total

1.  The future of laboratory medicine: understanding the new pressures.

Authors:  Mauro Panteghini
Journal:  Clin Biochem Rev       Date:  2004

2.  Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density.

Authors:  Ben-Chung Cheng; Ying-Chou Chen
Journal:  Clin Rheumatol       Date:  2016-10-18       Impact factor: 2.980

3.  Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.

Authors:  Senji Okuno; Masaaki Inaba; Kayoko Kitatani; Eiji Ishimura; Tomoyuki Yamakawa; Yoshiki Nishizawa
Journal:  Osteoporos Int       Date:  2004-08-11       Impact factor: 4.507

4.  A single-dose study of denosumab in patients with various degrees of renal impairment.

Authors:  Geoffrey A Block; Henry G Bone; Liang Fang; Edward Lee; Desmond Padhi
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

5.  Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.

Authors:  Alap L Christy; Vivian D'Souza; Ruby P Babu; Sohil Takodara; Poornima Manjrekar; Anupama Hegde; M S Rukmini
Journal:  Biomark Insights       Date:  2014-03-03

6.  Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.

Authors:  Mouna Bouksila; Mehdi Mrad; Wajih Kaabachi; Eya Kalai; Wided Smaoui; Sonia Rekik; Asma Krir; Nesrine Issaoui; Kamel Hamzaoui; Hela Sahli; Elhem Cheour El Kateb; Mohammed Karim Zouaghi; Afef Bahlous
Journal:  J Med Biochem       Date:  2019-07-30       Impact factor: 3.402
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.